SIRT1 and diabetes mellitus: In diabetes, SIRT1 suppresses low-grade micro-endothelial inflammation induced by chronic high glucose (HG) exposure by downregulating inflammatory cytokine production and nuclear factor κB (NF-κB) activity while promoting NO bioavailability and endothelial function [10,26,27,28].